Le Lézard
Classified in: Health, Science and technology
Subject: PET

Enso Discoveries, LLC Launches its Domestic, Independently Owned, No Contract or Volume Commitment, Histopathology Laboratory for Veterinary Industry and CROs


MANHATTAN, Kansas, March 25, 2020 /PRNewswire-PRWeb/ -- Enso Discoveries, LLC proudly announces the opening of its veterinary histopathology laboratory located centrally in the midwest for high-quality, quick-turn, board-certified reporting. In an effort to offer partnering clients the ability to work with a highly motivated, independent, professional team that is focused on incredible quality, turnaround time and value, Enso Discoveries has built the infrastructure and assembled the scientific expertise to readily meet ever-evolving needs of contract research organization clients.

"We envisioned this laboratory over a year ago after successfully working internationally in this space. Six months ago we hired Eric Pace, an outstanding, talented and experienced Laboratory Manager with incredible passion, to build, hire, train and certify our laboratory. We feel that laboratory independence is a lost art with so much consolidation going on and we intend to build great relationships and add great value, to those who appreciate the independent, no contract or volume commitment model," explains Patrick Farley, CEO of Enso Discoveries, LLC.

It is a continued commitment of Enso Discoveries to hire the best team of experts, pathologists and laboratory personnel to help provide priority lab services at non-priority lab prices. Under the watchful oversight of senior pathologists and experienced laboratory personnel, Enso Discoveries laboratory rigorously adheres to quality management standards applying technical and scientific expertise to every project, from routine procedures to highly specialized analyses.

Enso Discoveries Veterinary Histopathology Laboratory boasts:

"Our laboratory is a planned, high-production environment using the latest instruments such as the Leica Aperio AT2 imaging system that can process up to 400 slides an hour and dual Sakura tissue processors to ensure continued production. Our pathology network has extensive capacity to perform histologic processing and histopathologic evaluation of large quantities of tissue samples," Director of Laboratory Services, Eric Pace said. "I am continually impressed with the budget I am supported with which allows me access to the latest in equipment, the best of technology, and the hiring of an amazing staff. Our commitment to quality in our work, and getting cases out in a timely manner, with the willingness to go the extra mile will be what helps veterinarians make sure they are offering proper treatment to each and every animal patient."

Pace received his Bachelor's of Animal Science with a minor in Natural and Applied Sciences in May of 2000. He brings 15 years of histopathology experience ranging in research, forensics, private sector, and large hospital laboratory. As an ASCP certified histology technician, he has helped train and teach many students from histology programs to become certified histology technicians. Pace is also a member of the Society of Quality Assurance, National Society of Histology and American Society of Clinical Pathology.

Enso Discoveries, LLC is a biotech company focused on enhancing the lives of animals through the development of relevant, cost-effective, novel technology that allows our valued customer, the veterinarian, to keep their hard-earned business in house. We support our products and services with scientific proof, national distribution partners, and a worldwide network of industry experienced contacts. Ask your veterinarian or veterinary products distributor about Enso Discoveries, LLC products such as Rebound PRPtm and Rebound PRF® or learn more at http://www.ensodiscoveries.com.

 

SOURCE Enso Discoveries, LLC


These press releases may also interest you

at 05:10
Neurology Devices: Global Markets is basically a detailed study or report about the worldwide market for medical tools used in treating neurological conditions. These devices could be anything from equipment that helps stimulate the nervous system to...

at 05:04
Sirnaomics Ltd. (the "Company"; together with its subsidiaries, "Sirnaomics" or the "Group"; stock code: 2257), a leading biopharmaceutical company engaged in the discovery and development of advanced RNAi therapeutics, has announced its audited...

at 04:28
GymNation, the homegrown UAE fitness brand, has today announced that due to unprecedented growth, it is reaching capacity across its 12 UAE gym locations and diversifying into a new market, brewing up a storm with the launch of its first-ever branded...

at 04:00
Cancer spreads from its primary tumor to other parts of the body via blood or the lymphatic system in a process termed 'metastasis'. This usually represents an advanced stage in the disease's progression and tends to be fatal. Therefore, preventing...

at 03:30
Vicore Pharma Holding (STO:VICO)Sessions at ATS to include an oral late-breaking presentation of the final results from the Phase 2a AIR trial of buloxibutid (C21) in IPFAdditional presentations include preclinical and translational data reflecting...

at 03:13
Orexo's Annual and Sustainability Report for 2023 has been published and can be downloaded at, www.orexo.com. The Swedish version of the Report is also available on the company's website in European Single Electronic Format (ESEF). A PDF version is...



News published on and distributed by: